Telis Bioscience is a venture-backed biotechnology firm that develops protein therapeutics.
Telis Bioscience has raised $1.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2022.
Telis Bioscience's investors include Alameda Research.
Telis Bioscience is headquartered in Cambridge, United States.
Telis Bioscience is a venture-backed biotechnology firm that develops protein therapeutics.
Telis Bioscience is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Telis Bioscience — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/telis-bioscience. Accessed August 22, 2026.
VCBacked. (2022). Telis Bioscience — Funding & Investors. Retrieved August 22, 2026, from https://www.vcbacked.co/company/telis-bioscience
{{cite web |title=Telis Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/telis-bioscience |website=VCBacked |access-date=August 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated